Prof. Dr. Frank Stangenberg Haverkamp, Merck Foundation Board of Trustees emphasized, "Our aim is to improve the overall health and wellbeing of people by building healthcare capacity across Africa, ...

Firms with significant exposure to federal spending, government contracts and regulatory approvals are now tallying up the ...

Dr. Rasha Kelej highlighted the deepening collaboration between Merck Foundation and Cabo Verde, announcing that young ...

It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have added about 6.5% in that time frame, outperforming the S&P 500. But investors have to be ...

In today's Pharmalittle roundup, we're reading about FDA's Prasad defending his plans, a Merck setback in Germany, and more.

Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

Dow Jones Top Company Headlines at 11 PM ET: Masayoshi Son Hammers Out High-Tech Factories Plan With White House | Top ... The SoftBank billionaire is seeking to build "Trump Industrial Parks" on ...

In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing a new ...

Health-care companies fell sharply as traders rotated into sectors more sensitive to changes in interest rates. Halozyme was granted a preliminary injunction that would prevent Merck & Co. from ...

The Munich Regional Court ruled there was imminent infringement for Merck & Co.’s Keytruda SC in Germany related to ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), announced today that a German court has granted its request for a preliminary injunction ordering Merck to ...